Elanco Animal Health Incorporated Common Stock · Transaction Sep 23, 2025 · Filed Oct 10, 2025 · $1,001 to $15,000
Elanco Animal Health Inc
Follow $ELAN
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ELAN by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ELAN moving today?
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ELAN overview
Related filings and maps
Congress activity in ELAN
ELAN · Transaction Mar 6, 2023 · Filed Apr 17, 2023 · $1,001 to $15,000
Elanco Animal Health Incorporated · Transaction Mar 6, 2023 · Filed Apr 17, 2023 · $1,001 to $15,000
ELAN contract awards, year to date.
Public federal awards linked to this ticker.
ELAN lobbying filings, year to date.
Registered lobbying filings matched to Elanco Animal Health Inc.